Skip to main content
Premium Trial:

Request an Annual Quote

Agilent and Groton to Co-Market HPLC-Integrated Tool in North America

NEW YORK (GenomeWeb News) — Agilent Technologies and Groton Biosystems will co-market Groton’s Process Analytic Technology to pharmaceutical companies in North America, the companies said today.
 
PAT integrates Agilent’s 1200 series high-performance liquid chromatography instrument with Groton’s online sampling products and services. The tool is designed to help drug makers design, analyze, and control how raw and in-process materials are manufactured, the companies said. 
 
As part of the deal the firms will market the tools at trade shows, customer events, and product presentations, the companies said. 
 
The companies also said they expect in the “near future” to expand the agreement to Europe and Asia.
 
Financial terms of the agreement were not released.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.